Document text
Principal Investigator: DAVID B. WEINER
Organization: INTERNATIONAL SOCIETY OF VACCINES
Fiscal Year: 2024
Award: $7,000
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary / Abstract
The International Society for Vaccines (ISV) is a not-for-profit membership organization founded in
1992 with members and delegates from 47 countries, holding annual congresses since 2007. The ISV
Annual Congress is the world’s largest non-commercial scientific conference for researchers
interested in vaccines and immunotherapeutics and the underlying sciences. The topics include
prophylactic and therapeutic vaccines of infectious and chronic diseases and cancer, and human and
animal vaccines, including the intersection of One Health. Presentations cover basic research
through manufacturing and clinical trials.
ISV intentionally rotates the sites of the meetings between Asia, North America, and Europe, in
accessible locations for strong regional and international representation. ISV attracts renowned
leaders in vaccine fields while simultaneously providing opportunities for scientists from low- and
middle-income countries (LMICs) to attend both virtually and in person, and for students and early
career researchers (ECRs) to present and gain personalized feedback and mentoring by senior
scientists. ISV is particularly committed to ensuring participation of female, underrepresented, and
junior investigators.
The 2024 ISV Annual Congress, to be held in Seoul, South Korea, aims to highlight the very latest
ground-breaking developments in vaccine research, manufacturing, clinical development and
implementation, and safety. Plenary and parallel sessions are devoted to current hot topics spanning
diverse areas of vaccinology. Poster sessions will allow more free and diverse scientific exchange of
early research findings. Funding from NIAID R13 conference grant mechanism will provide critical
support to LMIC delegates and students in vaccinology.
Terms: <AI system><Acute Disease><Address><Adjuvant><Affect><Affinity><Age><Animals><Antibodies><Antigens><Area><Artificial Intelligence><Asia><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Basic Research><Basic Science><Biological Response Modifiers><Biomodulators><COVID-19><CV-19><Cancers><Chronic><Chronic Disease><Chronic Illness><Clinical Trials><Collaborations><Communicable Diseases><Communication><Communities><Computer Reasoning><Congresses><Coronavirus Infectious Disease 2019><Country><Development><Development and Research><Disease><Disease Outbreaks><Disorder><Domestic Animals><Elderly><Emerging Communicable Diseases><Emerging Infectious Diseases><Ensure><Epidemic><Epidemiology><Equilibrium><Europe><Event><Feedback><Female><Funding><Genetic Alteration><Genetic Change><Genetic defect><Geography><Global Warming><Goals><Grant><Grippe><Health><History><Human><Humoral Immunities><Ig Somatic Hypermutation><Immune><Immune Cell Activation><Immune Mediators><Immune Mediators/Modulators><Immune Regulators><Immune response><Immune system><Immunes><Immunity><Immunochemical Immunologic><Immunoglobulin Somatic Hypermutation><Immunologic><Immunologic Stimulation><Immunological><Immunological Stimulation><Immunological response><Immunologically><Immunologics><Immunologist><Immunostimulation><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapeutic agent><Impoverished><Individual><Infant><Infection><Infection prevention><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza><Ingestion><International><Investigators><LMIC><Learning><Life Cycle><Life Cycle Stages><Location><Machine Intelligence><Malignant Neoplasms><Malignant Tumor><Mentors><Modern Man><Mucosal Immunity><Mutation><NIAID><National Institute of Allergy and Infectious Disease><Needles><Neonatal><North America><Outbreaks><Persons><Policies><Population><Poverty><Prevent infection><Preventative vaccine><Preventive vaccine><Program Development><Prophylactic treatment><Prophylactic vaccine><Prophylaxis><R & D><R&D><RNA vaccine><RNA-based vaccine><Recording of previous events><Republic of Korea><Research><Research Personnel><Researchers><Rhinovirus><Rotation><Safety><Science><Scientific Advances and Accomplishments><Scientist><Senior Scientist><Site><Societies><South Korea><Specificity><Students><T cell response><T-Cells><T-Lymphocyte><Technology><Time><Toxic effect><Toxicities><Travel><United Nations><Update><Vaccination><Vaccine Antigen><Vaccine Research><Vaccines><Vector-borne disease><Vector-borne infectious disease><Vector-transmitted disease><Vector-transmitted infectious disease><Wild Animals><Work><acute disease/disorder><acute disorder><advanced age><ages><antibody-based immunity><balance><balance function><career><chronic disorder><clinical development><clinical implementation><conference><convention><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><develop a vaccine><develop vaccines><development of a vaccine><developmental><domesticated animal><epidemiologic><epidemiological><gain of function mutation><genome mutation><geriatric><histories><host response><immune activation><immune drugs><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immune-based therapeutics><immunogen><immunogenicity><immunologic therapeutics><immunomodulatory biologics><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive response><immunotherapeutics><immunotherapy agent><ingest><insight><interdisciplinary approach><interest><life course><low and middle-income countries><mRNA vaccine><mRNA-based vaccine><malignancy><manufacture><maternal immunization><maternal vaccination><meeting><meetings><member><microbiome><multidisciplinary approach><neoplasm/cancer><neutralizing antibody><new technology><new vaccines><next generation vaccines><novel technologies><novel vaccines><pandemic><pandemic disease><pathogen><posters><programs><research and development><response><scientific accomplishments><scientific advances><senior citizen><somatic hypermutation><summit><symposia><symposium><tech development><technology development><technology platform><technology system><therapeutic vaccine><thymus derived lymphocyte><tool><treatment vaccines><vaccine development><vaccine for the treatment><vaccine for treatment><vaccine strategy><vaccine-related research><vaccinology><vector-borne illness><vectorborne disease><vectorborne illness><vectorborne infectious disease><virtual>